View in EDS

BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90.

Saved in:
Bibliographic Details
Title: BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90.
Authors: Lundgren K; Biogen Idec, 5200 Research Place, San Diego, CA 92122, USA. karen.lundgren@biogenidec.com, Zhang H, Brekken J, Huser N, Powell RE, Timple N, Busch DJ, Neely L, Sensintaffar JL, Yang YC, McKenzie A, Friedman J, Scannevin R, Kamal A, Hong K, Kasibhatla SR, Boehm MF, Burrows FJ
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2009 Apr; Vol. 8 (4), pp. 921-9.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Print ISSN: 1535-7163 (Print) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 19372565
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lundgren+K%22">Lundgren K</searchLink>; Biogen Idec, 5200 Research Place, San Diego, CA 92122, USA. karen.lundgren@biogenidec.com<br /><searchLink fieldCode="AU" term="%22Zhang+H%22">Zhang H</searchLink><br /><searchLink fieldCode="AU" term="%22Brekken+J%22">Brekken J</searchLink><br /><searchLink fieldCode="AU" term="%22Huser+N%22">Huser N</searchLink><br /><searchLink fieldCode="AU" term="%22Powell+RE%22">Powell RE</searchLink><br /><searchLink fieldCode="AU" term="%22Timple+N%22">Timple N</searchLink><br /><searchLink fieldCode="AU" term="%22Busch+DJ%22">Busch DJ</searchLink><br /><searchLink fieldCode="AU" term="%22Neely+L%22">Neely L</searchLink><br /><searchLink fieldCode="AU" term="%22Sensintaffar+JL%22">Sensintaffar JL</searchLink><br /><searchLink fieldCode="AU" term="%22Yang+YC%22">Yang YC</searchLink><br /><searchLink fieldCode="AU" term="%22McKenzie+A%22">McKenzie A</searchLink><br /><searchLink fieldCode="AU" term="%22Friedman+J%22">Friedman J</searchLink><br /><searchLink fieldCode="AU" term="%22Scannevin+R%22">Scannevin R</searchLink><br /><searchLink fieldCode="AU" term="%22Kamal+A%22">Kamal A</searchLink><br /><searchLink fieldCode="AU" term="%22Hong+K%22">Hong K</searchLink><br /><searchLink fieldCode="AU" term="%22Kasibhatla+SR%22">Kasibhatla SR</searchLink><br /><searchLink fieldCode="AU" term="%22Boehm+MF%22">Boehm MF</searchLink><br /><searchLink fieldCode="AU" term="%22Burrows+FJ%22">Burrows FJ</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2009 Apr; Vol. 8 (4), pp. 921-9.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>1535-7163 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=19372565
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-08-0758
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 921
    Titles:
      – TitleFull: BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lundgren K
      – PersonEntity:
          Name:
            NameFull: Zhang H
      – PersonEntity:
          Name:
            NameFull: Brekken J
      – PersonEntity:
          Name:
            NameFull: Huser N
      – PersonEntity:
          Name:
            NameFull: Powell RE
      – PersonEntity:
          Name:
            NameFull: Timple N
      – PersonEntity:
          Name:
            NameFull: Busch DJ
      – PersonEntity:
          Name:
            NameFull: Neely L
      – PersonEntity:
          Name:
            NameFull: Sensintaffar JL
      – PersonEntity:
          Name:
            NameFull: Yang YC
      – PersonEntity:
          Name:
            NameFull: McKenzie A
      – PersonEntity:
          Name:
            NameFull: Friedman J
      – PersonEntity:
          Name:
            NameFull: Scannevin R
      – PersonEntity:
          Name:
            NameFull: Kamal A
      – PersonEntity:
          Name:
            NameFull: Hong K
      – PersonEntity:
          Name:
            NameFull: Kasibhatla SR
      – PersonEntity:
          Name:
            NameFull: Boehm MF
      – PersonEntity:
          Name:
            NameFull: Burrows FJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2009 Apr
              Type: published
              Y: 2009
          Identifiers:
            – Type: issn-print
              Value: 1535-7163
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1